# EDGAR Filing Document

**Accession Number:** 0001446159
**File Stem:** 0001171843-26-002096
**Filing Date:** 2026-3
**Character Count:** 18096
**Document Hash:** b99c721f112ae705439e611490f8a7f5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001171843-26-002096.hdr.sgml**: 20260331

**ACCESSION NUMBER**: 0001171843-26-002096

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20260331

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260331

**DATE AS OF CHANGE**: 20260331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Axe Compute Inc.
- **CENTRAL INDEX KEY:** 0001446159
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 331007393
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36790
- **FILM NUMBER:** 26822442

**BUSINESS ADDRESS:**
- **STREET 1:** 91 43RD STREET
- **STREET 2:** SUITE 110
- **CITY:** PITTSBURGH
- **STATE:** PA
- **ZIP:** 15201
- **BUSINESS PHONE:** 412-432-1500

**MAIL ADDRESS:**
- **STREET 1:** 91 43RD STREET
- **STREET 2:** SUITE 110
- **CITY:** PITTSBURGH
- **STATE:** PA
- **ZIP:** 15201

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Predictive Oncology Inc.
- **DATE OF NAME CHANGE:** 20190612

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Precision Therapeutics Inc.
- **DATE OF NAME CHANGE:** 20180314

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Precision Therapeutic Inc.
- **DATE OF NAME CHANGE:** 20180208

?xml version='1.0' encoding='ASCII'? Form 8-K

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

### Washington, D.C. 20549
_________________

### FORM 8-K
_________________

#### CURRENT REPORT

#### Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported): March 31, 2026
_______________________________

#### Axe Compute Inc.
(Exact name of registrant as specified in its charter)

_______________________________

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-36790** | **33-1007393** |
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |

---

#### 91 43rd Street, Suite 110

#### Pittsburgh, Pennsylvania 15201
(Address of Principal Executive Offices) (Zip Code)

(412) 432-1500

(Registrant's telephone number, including area code)

#### Predictive Oncology Inc.
(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common stock, $0.01 par value | AGPU | Nasdaq Capital Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 2.02. Results of Operations and Financial Condition.**

On March 31, 2026, Axe Compute Inc. (the "Company") issued a press release announcing its financial results for the year ended December 31, 2025. The Company is furnishing a copy of the press release, which is attached hereto as Exhibit 99.1.

In accordance with General Instruction B.2 of Form 8-K, the information set forth in this Current Report on Form 8-K (including Exhibit 99.1) is deemed to be "furnished" and shall not be deemed to be "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of the section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Exchange Act or Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits

---

| | |
|:---|:---|
| **<u>Exhibit No.</u>** | **<u>Description</u>** |
| [99.1](exh_991.htm) | [Press Release dated March 31, 2026](exh_991.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Axe Compute Inc.** | **Axe Compute Inc.** |
| Date: March 31, 2026 | By: | <u>/s/ Josh Blacher&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> |
|  |  | Josh Blacher |
|  |  | Chief Financial Officer |

---

## Exhibit 99.1

**EXHIBIT 99.1**

**Axe Compute Inc. Reports Full-Year 2025 Financial Results**

*Completed Strategic Transformation to AI Compute Infrastructure*

*Raised $343.5 Million in Capital to Fund Digital Asset Treasury Strategy*

*Solidified new leadership composition with world class CEO and board members*

PITTSBURGH, March 31, 2026 (GLOBE NEWSWIRE) -- **Axe Compute Inc.** (NASDAQ: AGPU), a technology company focused on providing enterprise access to high-performance GPU compute infrastructure for artificial intelligence workloads, today reported financial results for the fiscal year ended December 31, 2025. The year ended December 31, 2025, represented the Company's foundational year. During the year, Axe pivoted to become a GPU compute infrastructure and digital asset treasury company, encompassing a strategic repositioning, as well as completing a $343.5 million capital raise, and the establishing a distributed GPU network capable of supporting enterprise-scale artificial intelligence workloads.

Christopher Miglino, Chief Executive Officer, Axe Compute Inc. stated, "2025 was a pivotal year for Axe Compute. In less than ninety days, we raised $343.5 million in capital, established a Strategic Compute Reserve through a digital asset treasury position in the ATH AI token, and reconstituted our balance sheet from negative equity to $47.7 million in stockholders' equity. Our priorities for 2026 are driving revenue and growth."

**2025 BUSINESS AND OPERATIONAL MILESTONES**

* **Treasury Strategy Launched (September 2025):** The Company adopted a Strategic Compute Reserve focused exclusively on ATH, the native utility token of the Aethir decentralized GPU network. As of December 31, 2025, the Company held approximately 6.348 billion ATH in aggregate.

* **PIPE Capital Raise (October 2025):** Completed two concurrent private investment in public equity (PIPE) transactions totaling $343.5 million in gross proceeds, providing the Company's primary funding mechanism for the Strategic Compute Reserve.

* **Name Change (December 2025):** The Company changed its name from Predictive Oncology Inc. to Axe Compute Inc. effective December 11, 2025, and began trading under the ticker symbol AGPU on December 12, 2025.

* **Leadership Transition (February 2026):** Christopher Miglino was appointed Chief Executive Officer added to the board of directors effective February 9, 2026, succeeding Raymond Vennare. Mr. Miglino brings 25+ years of experience building and operating public technology, fintech, and digital asset companies.

* **Legacy Business Strategic Review (February 2026):** The Company began exploring strategic alternatives for its Helomics Drug Discovery Services business, including a potential sale, partnership, licensing arrangement, or other transaction. The review is ongoing and the Board has not committed to a specific course.

* **Board Reconstitution (March 2026):** New board members were appointed to the Board of Directors, adding semiconductor, technology, and international telecommunications expertise to the Company's governance structure.

* **GPU Network Access Established (March 2026):** The Company established enterprise customer access to a globally distributed GPU network of over 435,000 GPUs across more than 200 locations through the Aethir network infrastructure, capable of supporting enterprise-scale AI training, inference, fine-tuning, and high-performance compute workloads. Axe Compute does not own or operate the underlying data center facilities or GPU hardware; the Company's platform provides marketplace access to this network on an asset-light model.

**FULL YEAR 2025 FINANCIAL HIGHLIGHTS**

* **Total Revenue:** $125,284, derived entirely from the Company's Drug Discovery Services legacy segment. No compute revenue was recognized in fiscal 2025, as the Axe Compute segment launched in September 2025 and had not yet commenced revenue-generating compute deployments as of December 31, 2025.

* **Net Loss from Continuing Operations:** $232.9 million. Notable non-cash charges include: $152.5 million in unrealized losses on digital assets due to the decline in ATH's fair value from acquisition to year-end; $52.7 million loss on derivative instruments; and $16.6 million in non-cash stock-based compensation.

* **Cash Used in Continuing Operations:** $9.9 million for fiscal 2025, compared to $10.1 million in fiscal 2024, reflecting operational continuity at a controlled pace while the strategic infrastructure was established.

* **Cash and Cash Equivalents:** $10.8 million as of December 31, 2025, compared to $0.6 million as of December 31, 2024.

* **Digital Asset Holdings:** On December 31, 2025, we held approximately 2.837 billion unlocked ATH with a fair market value of $24.4 million, and a right to receive 3.511 billion locked ATH that are subject to vesting and/or transfer restrictions with a fair market value of $15.5 million after applying a discount for lack of transferability and control.

* **Total Assets:** $52.9 million as of December 31, 2025, compared to $5.0 million as of December 31, 2024.

* **Stockholders' Equity:** $47.7 million as of December 31, 2025, compared to a stockholders' deficit of $0.2 million as of December 31, 2024, representing a $47.9 million improvement driven largely by the October 2025 PIPE transactions.

* **Capital Raised:** $343.5 million in aggregate gross proceeds from the October 2025 PIPE transactions, comprising approximately $50.8 million in cash (Cash PIPE) and approximately $292.7 million in notional value of ATH contributed in-kind (Crypto PIPE, discounted value of $173.3 million).

**MARKET CONTEXT** 

Axe Compute operates against a backdrop of structural, supply-constrained demand for GPU compute infrastructure. Global AI spending is forecast to reach $2.52 trillion in 2026, a 44% increase year-over-year. Research estimates that approximately $6.7 trillion will be spent on data centers globally between 2025 and 2030, of which approximately 65.7% is GPU-related. As of early 2026, North American data center vacancy rates reached a record low of 1.6% and average GPU procurement lead times stand at 36 to 52 weeks. The Company believes this supply-demand imbalance creates a durable commercial opportunity for its distributed GPU compute model.

**OUTLOOK**

The Company does not provide formal financial guidance. The following forward-looking context is provided to assist investors in understanding management's operational priorities for 2026, and is subject to the risks and uncertainties described under the heading "Cautionary Statement Regarding Forward-Looking Statements" below.

Management's operational priorities for 2026 include: (i) deploying compute capacity to enterprise customers under reserved GPU capacity contracts, with the objective of generating initial Compute Services revenue; (ii) pursuing ATH staking activities to generate yield on the Company's treasury holdings; (iii) completing the strategic alternatives process for the Helomics legacy business; and (iv) advancing the Company's Strategic Compute Reserve , ATH treasury position through open market purchases where market conditions are favorable.

As of December 31, 2025, the Company had $10.8 million in cash and cash equivalents, and approximately 2.84 billion unlocked ATH tokens. Management believes the Company has access to sufficient liquidity sources to fund operations through fiscal 2026 and beyond, though results remain subject to ATH price volatility and other risks described in the Company's Annual Report on Form 10-K.

**FINANCIAL STATEMENTS** 

**SUMMARY BALANCE SHEETS**

Axe Compute Inc. \| As of December 31, 2025 and December 31, 2024

---

| | | |
|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2024** |
| ASSETS |  |  |
| Cash and cash equivalents | $10790850 | $611822 |
| Digital assets | 24439598 |  |
| Digital asset receivable (current) | 7226475 |  |
| Accounts receivable and other current assets | 313024 | 1614096 |
| **Total current assets** | 42769947 | 2225918 |
| Digital asset receivable (non-current) | 8258681 |  |
| Property, equipment and other non-current assets | 1859718 | 2746599 |
| **Total assets** | $52888346 | $4972517 |
| LIABILITIES & STOCKHOLDERS' EQUITY |  |  |
| **Total current liabilities** | $4266896 | $3593401 |
| Long-term lease and other non-current liabilities | 904495 | 1581726 |
| **Total liabilities** | 5171391 | 5175127 |
| **Total stockholders' equity (deficit)** | 47716955 | (202610) |
| **Total liabilities and stockholders' equity** | $52888346 | $4972517 |

---

**SUMMARY STATEMENTS OF NET LOSS**

Axe Compute Inc. \| Years Ended December 31, 2025 and 2024

---

| | | |
|:---|:---|:---|
| | **Year Ended Dec 31, 2025** | **Year Ended Dec 31, 2024** |
| Revenue | $125284 | $84812 |
| Gains (losses) on digital assets | (152490550) |  |
| Total operating expenses | 28550449 | 10388742 |
| **Total operating loss** | $(180915715) | $(10303930) |
| Gain (loss) on derivative instruments | (52735000) | 1376 |
| Other income (expense), net | 797068 | 77899 |
| Loss from continuing operations | $(232853647) | $(10224655) |
| Loss from discontinued operations | (241556) | (2439733) |
| **Net loss** | $(233095203) | $(12664388) |
| **Net loss per share — basic and diluted** | $(13.37) | $(34.83) |
| Weighted avg. shares outstanding — basic and diluted | 17429861 | 363583 |

---

**SUMMARY STATEMENTS OF CASH FLOWS** 

Axe Compute Inc. \| Years Ended December 31, 2025 and 2024

---

| | | |
|:---|:---|:---|
| | **Year Ended Dec 31, 2025** | **Year Ended Dec 31, 2024** |
| **Net cash used in continuing operations** | $(9876039) | $(10103084) |
| **Net cash used in investing (digital asset purchases)** | (32616819) | (9510) |
| **Net cash provided by financing activities** | 52006573 | 3939194 |
| **Net cash provided by (used in) discontinued operations** | 542462 | (1820587) |
| **Net increase (decrease) in cash** | $10056117 | $(7993987) |
| Cash — end of period | $10790850 | $611822 |

---

**CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS**

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, but are not limited to, statements regarding the Company's 2026 operational priorities, anticipated compute revenue generation, ATH staking activities, the strategic alternatives process for the Drug Discovery Services segment, the Company's liquidity and capital resources, and the market opportunity for GPU compute infrastructure. These statements are based on management's current expectations and beliefs as of the date of this release and are subject to significant risks and uncertainties that could cause actual results to differ materially, including but not limited to: the highly volatile and unpredictable price of ATH and digital assets generally; the Company's ability to generate compute revenue from its GPU network; risks associated with the Aethir network and decentralized physical infrastructure; the Company's ability to maintain Nasdaq listing compliance; risks related to the strategic alternatives process for the Drug Discovery Services business; and those risks and uncertainties described in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on March 31, 2026. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable law.

**ABOUT AXE COMPUTE**

<u>Axe Compute Inc</u>. (NASDAQ: AGPU) is a technology company focused on providing enterprise access to high-performance GPU compute infrastructure for artificial intelligence workloads. The Company provides enterprises, AI developers, and large-scale workload operators with on-demand access to over 435,000 GPUs across more than 200 global locations, with enterprise deployment as fast as 24 to 48 hours. The Company operates on a capital efficient model, and has adopted a strategic compute reserve strategy focused on ATH, the native utility token of the Aethir Network. Axe Compute is headquartered in Pittsburgh, Pennsylvania. For more information, visit

https://axecompute.com \| investors: <u>https://investors.axecompute.com</u>

**INVESTOR CONTACT** 

**Axe Compute Inc. — Investor Relations**

ir@axecompute.com \| investors.axecompute.com